A Top Novartis (NVS) Shareholder Says ‘The Party is Over’ for its Dealmaking Team

Summary

A top Novartis shareholder has criticized the company's dealmaking team, suggesting the period of active deal activity may be ending. The statement reflects shareholder concerns about the pharmaceutical company's acquisition and partnership strategy.